Premixed biphasic insulin is the most commonly prescribed insulin in Pakistan, as well as in neighbouring countries. This article describes the rationale of using premixed insulin both for initiation and intensification, the evidence in its favour, and the guidelines supporting its use. The review discusses recent advances in the field of premixed insulin, especially insulin degludec aspart combination.